Last reviewed · How we verify
NCT05771129
Feasibility Study of the Pulsed Electric Field Ablation System in Treating Chronic Bronchitis
NA trial testing Pulse electric field ablation system developed by Zhouling (Shanghai) Medical Appliance Co., Ltd. in Chronic Bronchitis in 15 participants. Status unknown.
10 March 2024
Quick facts
| Lead sponsor | Jiayuan Sun |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 15 |
| Start date | 10 March 2023 |
| Primary completion | 10 March 2024 |
| Estimated completion | 10 March 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- Pulse electric field ablation system developed by Zhouling (Shanghai) Medical Appliance Co., Ltd.
Conditions studied
- Chronic Bronchitis — all drugs for Chronic Bronchitis →
Sponsor
Jiayuan Sun
Who can join
Adults 35 to 80, any sex, with Chronic Bronchitis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To preliminarily evaluate the safety and feasibility of the pulsed electric field ablation system independently developed by Zhouling (Shanghai) Medical Appliance Co., Ltd. in the treatment of chronic bronchitis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05771129
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Chronic Bronchitis
Currently open trials in the same condition.
- NCT07068438 — Clinical Study of the Pulsed Electric Field Ablation System in Chronic Obstructive Pulmonary Disease · NA · recruiting
- NCT03049202 — BROnchoalveolar Investigations of Never-smokers With Chronic Obstruction From the Swedish CardioPulmonary bioImage Study · active not recruiting
Other Jiayuan Sun trials
Trials by the same sponsor.
- NCT07277088 — The Percutaneous Interventional Surgery Control System for Pulmonary Nodule Biopsy · NA · not yet recruiting
- NCT06572540 — Transthoracic vs Transbronchial Cryoablation for Early-stage Peripheral Lung Cancer · NA · recruiting
- NCT03903471 — 22G-ProCore vs 22G-Standard Needle in Diagnosis of Lymphadenopathy by EBUS-TBNA · NA · unknown
- NCT04413669 — Bronchoscopy Screening for High-risk Population of Lung Cancer With Severe Smoking With Negative LDCT Screen · NA · unknown
- NCT04182152 — Bronchoscopic ICG Injection and Percutaneous Hook-wire Techniques for Preoperative Lung Nodule Localization in VATS · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05771129 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jiayuan Sun
- Last refreshed: 16 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05771129.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing